biologic

Maci

autologous cultured chondrocytes on porcine collagen membrane

Loss of exclusivity—loss of exclusivity

CompanyVericel Corporation →See this company's full patent-cliff portfolio

Drug detail

Brand name	Maci
Active ingredient	autologous cultured chondrocytes on porcine collagen membrane
Strength	500,000 CM2 CM2
Dosage form	Cell Sheets
Route	Implantation
Modality	Biologic
Marketing status	Rx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.